Interaction Guide · Research summary

Can I take Iron with Levothyroxine?

Review Iron with Levothyroxine: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Taking iron at the same time as oral levothyroxine can reduce its absorption and worsen thyroid control. Direct clinical evidence is strongest for ferrous sulfate, and other iron preparations are not equally studied.

What this answer covers

Evidence concerns oral levothyroxine tablets, principally with ferrous sulfate; injectable levothyroxine is outside this finding.

Supplement or preparation
Iron
Medication ingredient
levothyroxine

Evidence and practical considerations

Absorption & effectiveness

A direct prospective patient study, complex-formation mechanism, guideline summaries, and current labeling consistently support clinically relevant loss of oral levothyroxine efficacy with simultaneous ferrous sulfate.

Exact scope
iron supplements with levothyroxine
Medication form and route
oral levothyroxine tablets
Timing or duration
Simultaneous daily dosing produced loss of biochemical control within 12 weeks.

What remains uncertain

  • Direct clinical evidence is strongest for ferrous sulfate, not every iron salt.
  • Evidence applies to oral levothyroxine; no injectable-route interaction is expected.
  • Product-label evidence requires the documented levothyroxine-sodium active-moiety bridge.

Factors that may matter: iron salt; iron dose; same-time dosing; oral formulation; baseline TSH stability.

Research conclusion: supported · Evidence assessment: moderate

Read the supporting source summaries

Source 1: peer-reviewed prospective human interaction study

pubmed.ncbi.nlm.nih.gov · Source check Jul 24, 2026

Population: Fourteen patients with hypothyroidism stable on levothyroxine.

Mean TSH increased from 1.6 to 5.4 mIU/L and nine patients developed increased hypothyroid symptoms; an insoluble ferric-thyroxine complex was observed in vitro.

Small, nonrandomized study of one iron salt; no long-term outcomes.

Source 2: current U.S. regulatory product labeling

dailymed.nlm.nih.gov · Source check Jul 24, 2026

Population: Patients using oral levothyroxine-sodium tablets.

Label identifies ferrous sulfate as an absorption-interfering agent and instructs at least four hours of separation.

Product-specific sodium-tablet label; evidence summary does not quantify all iron formulations.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Research summary published

Article revision: a8da44f5dbfb8716

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.